Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyBiologicalProcessspermatogenesis

TLK2 KDM3A SETX SPEM3 SPATA31A3 NUP210L SPATA31A7 SPATA31C2 SPATA31A6 SPATA31C1 SPATA31A5 SPATA31D4 SPATA31D3 ADAD2 SPATA31A1 HOOK1 EPC1 MEIOSIN SPATA22 VPS13B

4.33e-0874413020GO:0007283
GeneOntologyBiologicalProcessmale gamete generation

TLK2 KDM3A SETX SPEM3 SPATA31A3 NUP210L SPATA31A7 SPATA31C2 SPATA31A6 SPATA31C1 SPATA31A5 SPATA31D4 SPATA31D3 ADAD2 SPATA31A1 HOOK1 EPC1 MEIOSIN SPATA22 VPS13B

6.40e-0876213020GO:0048232
GeneOntologyBiologicalProcessdevelopmental process involved in reproduction

TLK2 KDM3A SETX SPEM3 SPATA31A3 NUP210L SPATA31A7 TUT7 SPATA31C2 APC ITGAV SPATA31A6 GRHL2 SPATA31C1 SPATA31A5 SPATA31D4 SPATA31D3 ADAD2 SPATA31A1 HOOK1 EPC1 MEIOSIN SPATA22 HECTD1 VPS13B

1.88e-07123513025GO:0003006
GeneOntologyBiologicalProcessgamete generation

TLK2 KDM3A SETX SPEM3 SPATA31A3 NUP210L SPATA31A7 TUT7 SPATA31C2 SPATA31A6 SPATA31C1 SPATA31A5 SPATA31D4 SPATA31D3 ADAD2 SPATA31A1 HOOK1 EPC1 MEIOSIN SPATA22 VPS13B

8.66e-0798213021GO:0007276
GeneOntologyBiologicalProcesssexual reproduction

TLK2 KDM3A SETX SPEM3 SPATA31A3 NUP210L SPATA31A7 TUT7 SPATA31C2 ITGAV SPATA31A6 SPATA31C1 SPATA31A5 SPATA31D4 SPATA31D3 ADAD2 SPATA31A1 HOOK1 ANAPC1 EPC1 MKI67 MEIOSIN SPATA22 VPS13B

2.09e-06131213024GO:0019953
GeneOntologyBiologicalProcessmulticellular organismal reproductive process

TLK2 KDM3A SETX SPEM3 SPATA31A3 NUP210L SPATA31A7 TUT7 SPATA31C2 SPATA31A6 SPATA31C1 SPATA31A5 SPATA31D4 SPATA31D3 ADAD2 SPATA31A1 HOOK1 EPC1 MEIOSIN SPATA22 VPS13B

1.80e-05119413021GO:0048609
GeneOntologyBiologicalProcessregulation of chromatin organization

TLK2 RESF1 EPC1 MKI67

1.15e-04401304GO:1902275
DomainDUF4599

SPATA31A3 SPATA31A7 SPATA31C2 SPATA31A6 SPATA31C1 SPATA31A5 SPATA31D4 SPATA31D3

1.77e-15121278PF15371
DomainDUF4599

SPATA31A3 SPATA31A7 SPATA31C2 SPATA31A6 SPATA31C1 SPATA31A5 SPATA31D4 SPATA31D3

1.77e-15121278IPR027970
DomainChemokine_CXC_CS

CXCL1 CXCL2 CXCL9

8.35e-05131273IPR018048
DomainCXC_Chemokine_domain

CXCL1 CXCL2 CXCL9

1.06e-04141273IPR033899
DomainChemokine_CXC

CXCL1 CXCL2 CXCL9

1.61e-04161273IPR001089
DomainSMALL_CYTOKINES_CXC

CXCL1 CXCL2 CXCL9

1.95e-04171273PS00471
DomainZINC_FINGER_C2H2_1

ZBTB48 TUT7 TRPS1 ZUP1 ZNF556 GLI3 ZNF644 ZNF516 ZNF667 ZBTB21 ZNF814 TSHZ1 ZNF518B ZNF682 ZNF114

2.59e-0477712715PS00028
DomainZnf_C2H2

ZBTB48 TUT7 TRPS1 ZUP1 ZNF556 GLI3 ZNF644 ZNF516 ZNF667 ZBTB21 ZNF814 TSHZ1 ZNF518B ZNF682 ZNF114

3.77e-0480512715IPR007087
DomainARM-like

RAP1GDS1 SETX INTS7 APC ARFGEF1 PDS5A HECTD1 MN1

5.23e-042701278IPR011989
PathwayREACTOME_ESTABLISHMENT_OF_SISTER_CHROMATID_COHESION

WAPL ESCO1 PDS5A

3.14e-0511833M27177
PathwayREACTOME_ESTABLISHMENT_OF_SISTER_CHROMATID_COHESION

WAPL ESCO1 PDS5A

3.14e-0511833MM14891
PathwayWP_COHESIN_COMPLEX_CORNELIA_DE_LANGE_SYNDROME

WAPL APC ESCO1 PDS5A

4.53e-0534834M42555
Pubmed

The testis-specific VAD1.3/AEP1 interacts with β-actin and syntaxin 1 and directs peri-nuclear/Golgi expression with bipartite nucleus localization (BNL) sequence.

SPATA31A3 SPATA31A7 SPATA31A6 SPATA31C1 SPATA31A5 SPATA31A1

2.92e-156134620850414
Pubmed

Targeted disruption of the spermatid-specific gene Spata31 causes male infertility.

SPATA31A3 SPATA31A7 SPATA31A6 SPATA31C1 SPATA31A5 SPATA31A1

2.92e-156134625930072
Pubmed

Majority of cerebrospinal fluid-contacting neurons in the spinal cord of C57Bl/6N mice is present in ectopic position unlike in other studied experimental mice strains and mammalian species.

SPATA31A3 SPATA31A7 SPATA31A6 SPATA31C1 SPATA31A5 SPATA31A1

3.71e-1024134632212159
Pubmed

Comprehensive Interactome Mapping of the DNA Repair Scaffold SLX4 Using Proximity Labeling and Affinity Purification.

TLK2 RANBP2 ATXN7L1 RESF1 BRCA1 SLF2 ZNF644 ZNF516 ZBTB21 PDS5A ZNF518B

1.16e-092221341137071664
Pubmed

Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.

KDM3A AGAP5 WAPL SETX FMNL3 STOX2 AFAP1 MRC2 ZNF516 ZBTB21 MED12L HMGXB3 AGAP9

1.49e-075291341314621295
Pubmed

DR3 signaling modulates the function of Foxp3+ regulatory T cells and the severity of acute graft-versus-host disease.

CXCL2 GZMH GZMB CXCL9 MKI67

1.71e-0733134527760760
Pubmed

Large-scale characterization of HeLa cell nuclear phosphoproteins.

TLK2 KDM3A RANBP2 WAPL GEMIN5 ANAPC1 ZNF644 GZMB ZNF516 ZBTB21 MKI67 LIMCH1 COIL MN1 MPG

3.35e-077741341515302935
Pubmed

Mutations of the Transcriptional Corepressor ZMYM2 Cause Syndromic Urinary Tract Malformations.

SETX TRPS1 RESF1 SLF2 ZNF644 ZNF516 ZBTB21

5.88e-07125134732891193
Pubmed

Cohesin acetylation speeds the replication fork.

WAPL ESCO1 PDS5A

1.11e-066134319907496
Pubmed

Interaction network of human early embryonic transcription factors.

NR2C1 RANBP2 TRPS1 RESF1 DNAAF10 ASXL3 ZNF644 ZNF516 EPC1 MKI67

1.16e-063511341038297188
Pubmed

CD4+ T cell memory is impaired by species-specific cytotoxic differentiation, but not by TCF-1 loss.

TNFRSF4 GZMH GZMB

1.94e-067134337122720
Pubmed

Systematic analysis of human protein complexes identifies chromosome segregation proteins.

TLK2 RANBP2 WAPL CNOT10 TRPS1 APC ESCO1 PHGDH TTBK2 STOX2 ANAPC1 PA2G4 ZNF644 MKI67 PDS5A COIL VPS13B

2.36e-0611551341720360068
Pubmed

Opposing Development of Cytotoxic and Follicular Helper CD4 T Cells Controlled by the TCF-1-Bcl6 Nexus.

TNFRSF4 GZMH GZMB

3.09e-068134327806296
Pubmed

Monocyte and neutrophil recruitment during oral Salmonella infection is driven by MyD88-derived chemokines.

CXCL1 CXCL2 CXCL9

3.09e-068134319839009
Pubmed

WECHE: a novel hematopoietic regulatory factor.

CXCL1 CXCL2 CXCL9

4.62e-069134310714680
Pubmed

Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.

NR2C1 RANBP2 TRPS1 APC GEMIN5 RESF1 ANAPC1 ZNF644 ZNF516 ZBTB21

5.48e-064181341034709266
Pubmed

Neural progenitor cells mediated by H2A.Z.2 regulate microglial development via Cxcl14 in the embryonic brain.

CXCL1 CXCL2 CXCL9 CD68

6.11e-0631134431712428
Pubmed

Assignment of the mouse and cow CXC chemokine genes.

CXCL1 CXCL2 CXCL9

6.58e-061013439730606
Pubmed

T cell infiltration and chemokine expression: relevance to the disease localization in murine graft-versus-host disease.

CXCL1 CXCL2 CXCL9

6.58e-0610134312098066
Pubmed

Sororin mediates sister chromatid cohesion by antagonizing Wapl.

WAPL ESCO1 PDS5A

6.58e-0610134321111234
Pubmed

Systematic proteomics of endogenous human cohesin reveals an interaction with diverse splicing factors and RNA-binding proteins required for mitotic progression.

RANBP2 WAPL SETX ESCO1 ANAPC1 MKI67 PDS5A KIAA2012

1.12e-05272134831010829
Pubmed

Delayed maturation and migration of excitatory neurons in the juvenile mouse paralaminar amygdala.

APC ASXL3 MKI67 TSHZ1

1.40e-0538134438086370
Pubmed

BRCA1 recruitment to transcriptional pause sites is required for R-loop-driven DNA damage repair.

SETX BRCA1

1.47e-052134225699710
Pubmed

Curcumin downregulates the inflammatory cytokines CXCL1 and -2 in breast cancer cells via NFkappaB.

CXCL1 CXCL2

1.47e-052134217999991
Pubmed

Cloning of two genes that are specifically expressed in activated cytotoxic T lymphocytes.

GZMH GZMB

1.47e-05213423485287
Pubmed

Granzyme B in injury, inflammation, and repair.

GZMH GZMB

1.47e-052134223099058
Pubmed

A novel lineage-specific hypersensitive site is essential for position independent granzyme B expression in transgenic mice.

GZMH GZMB

1.47e-052134218222115
Pubmed

Methylation Analysis of BRCA1 and APC in Breast Cancer and It's Relationship to Clinicopathological Features.

APC BRCA1

1.47e-052134228164568
Pubmed

Progesterone and calcitriol attenuate inflammatory cytokines CXCL1 and CXCL2 in ovarian and endometrial cancer cells.

CXCL1 CXCL2

1.47e-052134222615136
Pubmed

Copy number loss in granzyme genes confers resistance to immune checkpoint inhibitor in nasopharyngeal carcinoma.

GZMH GZMB

1.47e-052134233737344
Pubmed

Granzyme B-dependent proteolysis acts as a switch to enhance the proinflammatory activity of IL-1α.

GZMH GZMB

1.47e-052134222017873
Pubmed

Transcriptomic Profiling Reveals Chemokine CXCL1 as a Mediator for Neutrophil Recruitment Associated With Blood-Retinal Barrier Alteration in Diabetic Retinopathy.

CXCL1 CXCL2

1.47e-052134236930735
Pubmed

Analysis of protein processing by N-terminal proteomics reveals novel species-specific substrate determinants of granzyme B orthologs.

GZMH GZMB

1.47e-052134218836177
Pubmed

Characterization of a novel, human cytotoxic lymphocyte-specific serine protease cDNA clone (CSP-C).

GZMH GZMB

1.47e-05213422402757
Pubmed

Granzyme B is critical for T cell receptor-induced cell death of type 2 helper T cells.

GZMH GZMB

1.47e-052134216901729
Pubmed

Discordant regulation of granzyme H and granzyme B expression in human lymphocytes.

GZMH GZMB

1.47e-052134215069086
Pubmed

The herpes simplex virus type 1 latency-associated transcript can protect neuron-derived C1300 and Neuro2A cells from granzyme B-induced apoptosis and CD8 T-cell killing.

GZMH GZMB

1.47e-052134221177822
Pubmed

Studying the biology of cytotoxic T lymphocytes in vivo with a fluorescent granzyme B-mTFP knock-in mouse.

GZMH GZMB

1.47e-052134232696761
Pubmed

Requirement of MHC class I on radioresistant cells for granzyme B expression from CD8+ T cells in murine contact hypersensitivity.

GZMH GZMB

1.47e-052134229428817
Pubmed

Granzyme B deficiency exacerbates lung inflammation in mice after acute lung injury.

GZMH GZMB

1.47e-052134223642129
Pubmed

CXCL1 contributes to β-amyloid-induced transendothelial migration of monocytes in Alzheimer's disease.

CXCL1 CXCL2

1.47e-052134223967336
Pubmed

Molecular characterization and chromosomal mapping of melanoma growth stimulatory activity, a growth factor structurally related to beta-thromboglobulin.

CXCL1 CXCL2

1.47e-05213422970963
Pubmed

Regulation of tumor immune suppression and cancer cell survival by CXCL1/2 elevation in glioblastoma multiforme.

CXCL1 CXCL2

1.47e-052134233571109
Pubmed

TGF-β Negatively Regulates CXCL1 Chemokine Expression in Mammary Fibroblasts through Enhancement of Smad2/3 and Suppression of HGF/c-Met Signaling Mechanisms.

CXCL1 CXCL2

1.47e-052134226252654
Pubmed

Novel serine proteases encoded by two cytotoxic T lymphocyte-specific genes.

GZMH GZMB

1.47e-05213423518058
Pubmed

Structure and evolutionary origin of the human granzyme H gene.

GZMH GZMB

1.47e-05213422049336
Pubmed

Granzyme B mediates both direct and indirect cleavage of extracellular matrix in skin after chronic low-dose ultraviolet light irradiation.

GZMH GZMB

1.47e-052134225495009
Pubmed

Cytotoxic lymphocytes require granzyme B for the rapid induction of DNA fragmentation and apoptosis in allogeneic target cells.

GZMH GZMB

1.47e-05213428137431
Pubmed

Differential effects of reactive nitrogen species on DNA base excision repair initiated by the alkyladenine DNA glycosylase.

APC MPG

1.47e-052134219864471
Pubmed

Fas Ligand-mediated cytotoxicity of CD4+ T cells during chronic retrovirus infection.

GZMH GZMB

1.47e-052134228798348
Pubmed

The granzyme B gene is highly polymorphic in wild mice but essentially invariant in common inbred laboratory strains.

GZMH GZMB

1.47e-052134217661907
Pubmed

Chemokine (C-X-C motif) ligand 1 and CXCL2 produced by tumor promote the generation of monocytic myeloid-derived suppressor cells.

CXCL1 CXCL2

1.47e-052134230259595
Pubmed

A role for the granzyme B inhibitor serine protease inhibitor 6 in CD8+ memory cell homeostasis.

GZMH GZMB

1.47e-052134215356127
Pubmed

Dysregulation of CXCL1 Expression and Neutrophil Recruitment in Insulin Resistance and Diabetes-Related Periodontitis in Male Mice.

CXCL1 CXCL2

1.47e-052134237058471
Pubmed

Role of Bid-induced mitochondrial outer membrane permeabilization in granzyme B-induced apoptosis.

GZMH GZMB

1.47e-052134216405654
Pubmed

Functionally independent AU-rich sequence motifs regulate KC (CXCL1) mRNA.

CXCL1 CXCL2

1.47e-052134215994316
Pubmed

The proinflammatory CXC-chemokines GRO-alpha/CXCL1 and MIG/CXCL9 are concomitantly expressed in ulcerative colitis and decrease during treatment with topical corticosteroids.

CXCL1 CXCL9

1.47e-052134217703315
Pubmed

Granzyme B is dispensable in the development of diabetes in non-obese diabetic mice.

GZMH GZMB

1.47e-052134222792290
Pubmed

Esco1 Acetylates Cohesin via a Mechanism Different from That of Esco2.

ESCO1 PDS5A

1.47e-052134226051894
Pubmed

Organization of two genes encoding cytotoxic T lymphocyte-specific serine proteases CCPI and CCPII.

GZMH GZMB

1.47e-05213423264185
Pubmed

Ki-67 regulates global gene expression and promotes sequential stages of carcinogenesis.

APC MKI67

1.47e-052134233658388
Pubmed

Inhibitory Effect of Zinc on Colorectal Cancer by Granzyme B Transcriptional Regulation in Cytotoxic T Cells.

GZMH GZMB

1.47e-052134237298408
Pubmed

Genetic deletion of granzyme B does not confer resistance to the development of spontaneous diabetes in non-obese diabetic mice.

GZMH GZMB

1.47e-052134223663075
Pubmed

Cloning of a gene that encodes a new member of the human cytotoxic cell protease family.

GZMH GZMB

1.47e-05213422193684
Pubmed

Polymorphisms in the promoter regions of the CXCL1 and CXCL2 genes contribute to increased risk of alopecia areata in the Korean population.

CXCL1 CXCL2

1.47e-052134226345899
Pubmed

Associations between Genetic Variants and Angiographic Characteristics in Patients with Coronary Artery Disease.

TRPS1 CPNE4

1.47e-052134225328121
Pubmed

Rapid reuptake of granzyme B leads to emperitosis: an apoptotic cell-in-cell death of immune killer cells inside tumor cells.

GZMH GZMB

1.47e-052134224113190
Pubmed

A cluster of hematopoietic serine protease genes is found on the same chromosomal band as the human alpha/delta T-cell receptor locus.

GZMH GZMB

1.47e-05213422300587
Pubmed

Mouse and human granzyme B have distinct tetrapeptide specificities and abilities to recruit the bid pathway.

GZMH GZMB

1.47e-052134217179148
Pubmed

Cytotoxic CD8+ T cells promote granzyme B-dependent adverse post-ischemic cardiac remodeling.

GZMH GZMB

1.47e-052134233674611
Pubmed

Double mutation of APC and BRCA1 in an Italian family.

APC BRCA1

1.47e-052134232388397
Pubmed

Activation of the apoptotic protease CPP32 by cytotoxic T-cell-derived granzyme B.

GZMH GZMB

1.47e-05213427566124
Pubmed

Granzyme B-Mediated Activation-Induced Death of CD4+ T Cells Inhibits Murine Acute Graft-versus-Host Disease.

GZMH GZMB

1.47e-052134226392464
Pubmed

Differential cleavage of viral polypeptides by allotypic variants of granzyme B skews immunity to mouse cytomegalovirus.

GZMH GZMB

1.47e-052134232473350
Pubmed

Granule-derived granzyme B mediates the vulnerability of human neurons to T cell-induced neurotoxicity.

GZMH GZMB

1.47e-052134221964027
Pubmed

Distinct patterns of cytolytic T-cell activation by different tumour cells revealed by Ca2+ signalling and granule mobilization.

GZMH GZMB

1.47e-052134227716898
Pubmed

Granzyme B deficiency promotes osteoblastic differentiation and calcification of vascular smooth muscle cells in hypoxic pulmonary hypertension.

GZMH GZMB

1.47e-052134229445095
Pubmed

Gene-gene interaction between RBMS3 and ZNF516 influences bone mineral density.

RBMS3 ZNF516

1.47e-052134223045156
Pubmed

Granzyme B Disrupts Central Metabolism and Protein Synthesis in Bacteria to Promote an Immune Cell Death Program.

GZMH GZMB

1.47e-052134229107333
Pubmed

A CXCL1 paracrine network links cancer chemoresistance and metastasis.

CXCL1 CXCL2

1.47e-052134222770218
Pubmed

Constitutive overexpression of a growth-regulated gene in transformed Chinese hamster and human cells.

CXCL1 CXCL2

1.47e-05213422890161
Pubmed

Visualization of granzyme B-expressing CD8 T cells during primary and secondary immune responses to Listeria monocytogenes.

GZMH GZMB

1.47e-052134225367158
Pubmed

Structure and expression of a cluster of human hematopoietic serine protease genes found on chromosome 14q11.2.

GZMH GZMB

1.47e-05213422007574
Pubmed

Maternal diesel particle exposure promotes offspring asthma through NK cell-derived granzyme B.

GZMH GZMB

1.47e-052134232407293
Pubmed

Regulatory T cells expressing granzyme B play a critical role in controlling lung inflammation during acute viral infection.

GZMH GZMB

1.47e-052134222236998
Pubmed

Domain and functional analysis of a novel platelet-endothelial cell surface protein, SCUBE1.

SCUBE1 MKI67

1.47e-052134218303018
Pubmed

Differential expression of granzyme B and C in murine cytotoxic lymphocytes.

GZMH GZMB

1.47e-052134219414782
Pubmed

Granzyme B releases vascular endothelial growth factor from extracellular matrix and induces vascular permeability.

GZMH GZMB

1.47e-052134224791744
Pubmed

Activated mouse B cells lack expression of granzyme B.

GZMH GZMB

1.47e-052134222427643
Pubmed

Impact of CXCL1 overexpression on growth and invasion of prostate cancer cell.

CXCL1 CXCL2

1.47e-052134223334998
Pubmed

Granule-mediated killing by granzyme B and perforin requires a mannose 6-phosphate receptor and is augmented by cell surface heparan sulfate.

GZMH GZMB

1.47e-052134216280358
Pubmed

Granzyme B plays a critical role in cytotoxic lymphocyte-induced apoptosis.

GZMH GZMB

1.47e-05213427493755
Pubmed

Sepsis alters the megakaryocyte-platelet transcriptional axis resulting in granzyme B-mediated lymphotoxicity.

GZMH GZMB

1.47e-052134219136373
Pubmed

Granzyme B prevents aberrant IL-17 production and intestinal pathogenicity in CD4+ T cells.

GZMH GZMB

1.47e-052134234183776
Pubmed

Granzyme B Contributes to Barrier Dysfunction in Oxazolone-Induced Skin Inflammation through E-Cadherin and FLG Cleavage.

GZMH GZMB

1.47e-052134232504614
Pubmed

Cloning and sequence of a secretory protein induced by growth factors in mouse fibroblasts.

CXCL1 CXCL2

1.47e-05213422909392
Pubmed

Granzyme B and the downstream granzymes C and/or F are important for cytotoxic lymphocyte functions.

GZMH GZMB

1.47e-052134215699143
Pubmed

[Correlation of BRCA1 and APC aberrant methylation with the response to anthracycline-based neoadjuvant chemotherapy in primary breast cancer].

APC BRCA1

1.47e-052134219615284
Pubmed

Interplay between chromatin remodeling and epigenetic changes during lineage-specific commitment to granzyme B expression.

GZMH GZMB

1.47e-052134219915065
Pubmed

Marrow adipocyte-derived CXCL1 and CXCL2 contribute to osteolysis in metastatic prostate cancer.

CXCL1 CXCL2

1.47e-052134225802102
InteractionNUP43 interactions

KDM3A NR2C1 RANBP2 SETX NSD1 APC RYR2 RESF1 BRCA1 HOOK1 SLF2 ZNF644 EPC1 MKI67 COIL

8.55e-0662512615int:NUP43
InteractionTRIM52 interactions

CCDC14 SETX INTS7 DIP2A ZNF644 PDZRN3 ALG13

2.05e-051331267int:TRIM52
InteractionMAU2 interactions

RANBP2 WAPL SETX ATXN7L1 BRCA1 ANAPC1 MKI67

2.36e-051361267int:MAU2
Cytoband4q21

CXCL1 CXCL2 CXCL9

2.67e-052013434q21
CytobandEnsembl 112 genes in cytogenetic band chr9q12

SPATA31A7 SPATA31A5

2.34e-0481342chr9q12
GeneFamilyAnkyrin repeat domain containing

AGAP5 ANKRD36C ASB3 ANKRD61 ANKRD36 AGAP9 HECTD1 NOTCH4

1.06e-05242798403
GeneFamilyZinc fingers C2H2-type|ZF class homeoboxes and pseudogenes

ZBTB48 TRPS1 ZUP1 ZNF556 GLI3 ZNF516 ZNF667 ZBTB21 ZNF814 TSHZ1 ZNF518B ZNF682 ZNF114

1.29e-05718791328
GeneFamilyChemokine ligands|Endogenous ligands

CXCL1 CXCL2 CXCL9

9.98e-0445793483
GeneFamilyX-linked mental retardation|Rho GTPase activating proteins|BAR-PH domain containing

AGAP5 AGAP9

2.46e-03177921291
CoexpressionPATEL_SKIN_OF_BODY_ZOSTAVAX_AGE_70_93YO_VZV_CHALLENGE_6HR_TOP_30_DEG_UP

ADAMTS8 CXCL1 CXCL2 GZMB CXCL9

2.67e-07291275M40976
CoexpressionRODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP

CCDC14 RAP1GDS1 WAPL IMPDH1 INTS7 APC PHGDH GFM2 RESF1 BRCA1 ZNF644 MKI67 AMIGO2

1.55e-0564412713M10501
CoexpressionDACOSTA_UV_RESPONSE_VIA_ERCC3_DN

SECISBP2L TLK2 KDM3A RANBP2 WAPL SETX APC ARFGEF1 AFAP1 ZFYVE9 BRCA1 PDS5A MN1 VPS13B PHLPP2

1.77e-0585612715M4500
CoexpressionAtlasDevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#4_top-relative-expression-ranked_1000

SETX TRPS1 APC RYR2 STOX2 ANAPC1 ASXL3 GLI3 ERCC6L2 ZNF518B VPS13B

2.05e-0538512711gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000_k4
CoexpressionAtlasDevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_1000

SETX MSC ATXN7L1 TRPS1 APC IRAG1 GRHL2 DACT1 STOX2 ANAPC1 MRC2 GLI3 ERCC6L2 MKX ZNF518B MN1

2.56e-0580612716gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000
CoexpressionAtlasDevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_k-means-cluster#5_top-relative-expression-ranked_1000

SETX TRPS1 NSD1 APC RYR2 STOX2 RESF1 ANAPC1 GLI3 ERCC6L2 ZNF518B

2.72e-0539712711gudmap_developingLowerUrinaryTract_e14.5_ bladder_1000_k5
CoexpressionAtlasFacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#4

IQSEC3 WAPL SETX TRPS1 ASXL3 GLI3 ZNF644 MKI67 LIMCH1

7.81e-052981279Facebase_RNAseq_e10.5_Medial Nasal Eminence_1000_K4
CoexpressionAtlasDevelopingKidney_e15.5_Peripheral blastema_emap-27731_k-means-cluster#3_top-relative-expression-ranked_1000

IRAG1 DACT1 TTBK2 ANAPC1 ASXL3 ASB3 ZBTB21 MN1 AMIGO2

9.79e-053071279gudmap_developingKidney_e15.5_Peripheral blastema_1000_k3
CoexpressionAtlasFacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1

TLK2 NR2C1 RANBP2 RAP1GDS1 WAPL SETX APC ZFYVE9 GLI3 PDS5A HECTD1

1.21e-0446912711Facebase_RNAseq_e8.5_Floor Plate_2500_K1
ToppCellLPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ADAMTS8 RYR2 ADH4 STOX2 AFAP1 MRC2 LIMCH1 PDZRN3

1.18e-071921338deeecd26972241846b4cb998edf0c7a87ff0c4df
ToppCellTCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9

WAPL SETX APC IRAG1 RESF1 ZNF644 VPS13B

1.48e-06186133703db813598b67b1e08f759758a1c2023396921fa
ToppCellLPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ADAMTS8 RYR2 ADH4 AFAP1 MRC2 LIMCH1 PDZRN3

1.76e-061911337b13229bb7f3713a392271aaf5dbae3edd1b9fe5a
ToppCellLPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ADAMTS8 ADH4 AFAP1 MRC2 ASXL3 LIMCH1 PDZRN3

1.89e-061931337fb28717fadd06c3840636d25409ce80c9254bd34
ToppCellLPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ADAMTS8 ADH4 AFAP1 MRC2 ASXL3 LIMCH1 PDZRN3

1.96e-06194133789b706af2b25991fc2707eb24f49ba6ff3ae01f7
ToppCellLPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type

ADAMTS8 RYR2 AFAP1 RBMS3 MRC2 LIMCH1 PDZRN3

2.17e-061971337fdb92985f7df0c280b87d3e43c2394e70786a2c7
ToppCell3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

ADAMTS8 RYR2 DACT1 RBMS3 MRC2 LIMCH1 PDZRN3

2.17e-06197133794a9603cbd3516fbcce871909693b88f20d41713
ToppCellmild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

TLK2 ARFGEF1 ANKRD36C DIP2A ZNF644 ANKRD36 VPS13B

2.32e-061991337f0b0097df0026496470a80d8cc9375ffd8389b00
ToppCellLPS_only-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type

ADAMTS8 AFAP1 RBMS3 MRC2 CD81 LIMCH1 PDZRN3

2.32e-061991337fde2b65afde69f402f1b7b056eaa266e9fd5b227
ToppCellLPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type

ADAMTS8 RYR2 ADH4 AFAP1 MRC2 LIMCH1 PDZRN3

2.32e-061991337a7dd94b172c973a131a6792f8ccd9bfe44d984ac
ToppCellLPS_only-Mesenchymal_fibroblastic|LPS_only / Treatment groups by lineage, cell group, cell type

ADAMTS8 ADH4 AFAP1 MRC2 CD81 LIMCH1 PDZRN3

2.32e-061991337211c3a08f2d484ab7a3368006767289088f0d957
ToppCellLPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type

ADAMTS8 RYR2 AFAP1 RBMS3 MRC2 LIMCH1 PDZRN3

2.32e-0619913378b86c69aaf60feff53aa782559cfece7342a23de
ToppCellLPS_only-Mesenchymal_fibroblastic-Fibroblasts|LPS_only / Treatment groups by lineage, cell group, cell type

ADAMTS8 ADH4 AFAP1 MRC2 CD81 LIMCH1 PDZRN3

2.32e-0619913371a0add79f4e34078b3475eb11c85a4234bda197c
ToppCellLPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type

ADAMTS8 ADH4 AFAP1 MRC2 CD81 LIMCH1 PDZRN3

2.39e-062001337b79628fd1386aa9a3b0e9fa81def0bc100c3c073
ToppCellLPS_anti-TNF-Mesenchymal_fibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type

ADAMTS8 ADH4 AFAP1 MRC2 CD81 LIMCH1 PDZRN3

2.39e-06200133750ca6550998e461ef26dd670351060bd940765a8
ToppCellLPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type

ADAMTS8 ADH4 AFAP1 MRC2 CD81 LIMCH1 PDZRN3

2.39e-06200133744a68bacdb3d5bf563bd35952176995850933a81
ToppCellLPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type

ADAMTS8 RYR2 ADH4 MRC2 CD81 LIMCH1 PDZRN3

2.39e-062001337a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2
ToppCellLPS_IL1RA_TNF-Mesenchymal_fibroblastic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type

ADAMTS8 ADH4 AFAP1 MRC2 CD81 LIMCH1 PDZRN3

2.39e-062001337dc61016c61729f69649cfb21f6264e685ce83dea
ToppCelltumor_Lymph_Node_/_Brain-Myeloid_cells-pDCs|Myeloid_cells / Location, Cell class and cell subclass

IQSEC3 ZNF556 DNAAF10 GZMB ZNF667 PHLPP2

7.53e-06156133619472ef1642c2ad333aa3ce3675a25c6ab1d4556
ToppCell3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells-CD8_T_cells_L.1.1.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

ADAMTS8 IRAG1 RYR2 GLI3 GZMH GZMB

1.07e-05166133626f3d5e5e30b63b09b89cda23c423d12d887631f
ToppCelldroplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

RANBP2 WAPL NUP210L TUT7 NSD1 CXCL9

1.59e-05178133601dafd19de04eff459253eaa9a35debf8f3deedf
ToppCelldroplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SETX NSD1 APC CXCL2 SLF2 PDS5A

1.92e-0518413361154a5ad7b8512272b7476f949ddac350910bfb7
ToppCellEpithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|World / Lineage, Cell type, age group and donor

SECISBP2L MAGI3 GRHL2 STOX2 LIMCH1 ZNF682

2.11e-05187133681cc8435b2704a9a8287b3f54acaae0f11dd4ac7
ToppCell368C-Lymphocytic-NK_cells-NK_cell_D3|368C / Donor, Lineage, Cell class and subclass (all cells)

TNFRSF4 AFAP1 GZMH GZMB ANKRD36 ZNF682

2.17e-051881336ecc2364d946f97ae0212fd6739960c9fc75e4919
ToppCell-Donor_07|World / lung cells shred on cell class, cell subclass, sample id

MSC ADAMTS8 TNFRSF4 GZMH GZMB PDZRN3

2.17e-051881336038f48e8daaeb72716e975d22a6b004a90654960
ToppCellLPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ADAMTS8 ADH4 AFAP1 MRC2 LIMCH1 PDZRN3

2.24e-051891336a153b83314cf52808f685296cff8c95af3f4983d
ToppCellLPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ADAMTS8 ADH4 AFAP1 MRC2 LIMCH1 PDZRN3

2.24e-051891336e9d5e858e320c6e9913c1ea6a54967d21eda605f
ToppCellFetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

SECISBP2L MAGI3 PRAG1 GRHL2 STOX2 LIMCH1

2.30e-0519013368aea807a2bcf0b653b4de6202b6ecb0f0683cc2e
ToppCellLPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ADAMTS8 ADH4 AFAP1 MRC2 LIMCH1 PDZRN3

2.44e-0519213366f4ef24dab544681304b7f8a9dc073e7edaa4cf5
ToppCellLPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ADAMTS8 RYR2 AFAP1 MRC2 LIMCH1 PDZRN3

2.44e-051921336f4fc2b0121f879bab2bee99dfb5ff2c3ca1c0e1b
ToppCellLPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ADAMTS8 ADH4 AFAP1 MRC2 LIMCH1 PDZRN3

2.44e-051921336dcd924d6eb67d33ee9f5d3e8ab6e1d4283d6b708
ToppCellLPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ADAMTS8 ADH4 AFAP1 MRC2 LIMCH1 PDZRN3

2.59e-05194133660622bd2f75bfe4c37f721cb12f03dab33f2f58d
ToppCellFetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

RYR2 SLF2 MRC2 GLI3 LIMCH1 PDZRN3

2.59e-05194133635f132cc38ac133be01834ed0946188aa0757eb4
ToppCell10x5'-GI_small-bowel-Myeloid_Mac-Intestinal_macrophages|GI_small-bowel / Manually curated celltypes from each tissue

CXCL1 CXCL2 CLEC4F MCTP1 MRC2 CD68

2.74e-051961336075e5746fa5cb121115a1d51b823c0fbf8d54305
ToppCellCOVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations)

RYR2 AFAP1 RBMS3 MRC2 GLI3 PDZRN3

2.82e-051971336f1c8936986123a3151140c374fcd62d6705c530b
ToppCellCOPD-Stromal-Myofibroblast|World / Disease state, Lineage and Cell class

ADAMTS8 RYR2 RBMS3 MRC2 LIMCH1 PDZRN3

2.82e-051971336d51f484b4e01ac64233950d0b97fa88825ea1dbb
ToppCell3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

SECISBP2L TAPT1 CXCL2 MRC2 DUSP16 LIMCH1

2.82e-051971336bf10727fbe90b71d2ac60a11711e5f0701b3799d
ToppCellTracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

ADAMTS8 IRAG1 RYR2 SCUBE1 MN1 PDZRN3

2.82e-051971336ac4f53acb2f8a428b0f2fab3c30a34e095a1bed7
ToppCellmild-pDC|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

FMNL3 RBMS3 GZMB MED12L PDZRN3 NOTCH4

2.82e-05197133615230a54fa5903dd728de1a0ad633bd2d2c7a04d
ToppCellFetal_29-31_weeks|World / Lineage, Cell type, age group and donor

RYR2 AFAP1 RBMS3 ASXL3 CD81 PDZRN3

2.99e-0519913365b9d355795dd03a22f0961dfd143425c367a4654
ToppCellBrain_organoid-organoid_Kanton_Nature-Organoid-4M|organoid_Kanton_Nature / Sample Type, Dataset, Time_group, and Cell type.

APC ANKRD36C AFAP1 CD81 ANKRD36 PDZRN3

2.99e-051991336b2d7dea11207cca63d688f8051143850b29dbdf0
ToppCellLPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type

ADAMTS8 AFAP1 MRC2 CD81 LIMCH1 PDZRN3

2.99e-05199133630d3e8c0681ec11f86dd38c5f48d21187a1b4f90
ToppCellLPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type

ADAMTS8 AFAP1 MRC2 CD81 LIMCH1 PDZRN3

2.99e-051991336e1849505b92820a219c5a2c35492bdd55579fb48
ToppCellLPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type

ADAMTS8 ADH4 AFAP1 MRC2 LIMCH1 PDZRN3

3.07e-0520013369b0916d8d07ac2bf1739f7be5296bf77ffee6094
ToppCellLPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type

ADAMTS8 AFAP1 MRC2 CD81 LIMCH1 PDZRN3

3.07e-0520013363bdba9612cd7c612b76aa9abecc4a6529aabfc1c
ToppCellVE-CD8-exh_CD4|VE / Condition, Cell_class and T cell subcluster

TRPS1 SCUBE1 RESF1 GZMH CD81

5.15e-0513413354413fec495907184b6d5cf4bda39359506b2c172
ToppCellfrontal_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Vipr2|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

TRPS1 ADAMTS8 PHGDH AFAP1 GZMH

6.34e-05140133572c272f44e5600b3037c1dbf9d3a4669a35588d8
ToppCellHealthy_Control-Myeloid-Macrophages-FCN1_high|Healthy_Control / Condition, Lineage, Cell class and cell subclass

GLI3 FAM157C CXCL9 EIF4E3 NOTCH4

1.03e-041551335cd2ccb4632713b4def3a1064599b78207e2e44c0
ToppCell368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1.5|368C / Donor, Lineage, Cell class and subclass (all cells)

AGAP5 SLC26A2 BRCA1 GZMH GZMB

1.12e-041581335390b9c455ed15a6804613eecfd2776949dfba146
ToppCellfacs-Lung-ENDOMUCIN-18m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ZFYVE9 DUSP16 MKI67 CD68 INSYN2B

1.19e-0416013352020b6defbaf5b5db12af37f0103ac028a8ca76e
ToppCellfacs-Lung-ENDOMUCIN-18m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ZFYVE9 DUSP16 MKI67 CD68 INSYN2B

1.19e-041601335af7cf0dc5fe7c02f7d6c436f6dde766c79ff0eae
ToppCelldroplet-Marrow-nan-18m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

KDM3A SLC26A2 ITGAV DIP2A DUSP16

1.23e-0416113353f3a2148c8d65e6a06f8d8116a3aa58dda17d618
ToppCellfrontal_cortex-Neuronal-GABAergic_neuron-Pvalb|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

ADAMTS8 PHGDH AFAP1 RBMS3 MKX

1.30e-041631335db6b7ce6f7221bb73c5e650ac51cdd5d7ef00675
ToppCellfrontal_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Reln_Tac1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

ADAMTS8 PHGDH AFAP1 RBMS3 MKX

1.37e-041651335d8df50f5a3b646e8ea13739fdc65ce6f39b4d4d2
ToppCellprimary_visual_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Reln_Tac1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

ADAMTS8 PHGDH AFAP1 RBMS3 MKX

1.41e-04166133559d47c1fca7a8c70f6998f3367a9dbcb9b67966f
ToppCell390C-Lymphocytic-NK_cells-NK_cell_E|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)

CCDC14 MAGI3 TNFRSF4 AFAP1 PHLPP2

1.45e-0416713356c2dade24a88af04b2c90a7e4f8dd7ccea9e94d1
ToppCell3'_v3-lymph-node_spleen-Hematopoietic_progenitors-Progenitor|lymph-node_spleen / Manually curated celltypes from each tissue

MRC2 ASXL3 ZNF667 MED12L MN1

1.45e-041671335cb396f3edb9e8fdc316091e8e193dbba50e0be0c
ToppCellSomatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L5-6_RORB_LINC00320|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

DCHS2 CXCL1 SLC22A18 TSHZ1 CPNE4

1.49e-0416813353db0453296914011b733b82234b3e8e45ebc86b6
ToppCell368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1.5|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)

AGAP5 SLC26A2 BRCA1 GZMH GZMB

1.49e-04168133594cded2e953c0970bf2f3dbe0ce46bd77a5ed8c7
ToppCelldroplet-Lung-21m-Hematologic-myeloid-interstitial_macrophage|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

CXCL1 CLEC4F ANKRD61 CD68 CD81

1.49e-04168133506787d4f08ddf052127404a0ea6a85e1b048e206
ToppCellprimary_visual_cortex-Neuronal-GABAergic_neuron-Pvalb|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

ADAMTS8 PHGDH AFAP1 RBMS3 MKX

1.49e-0416813352572a3dd4f3f619bd26a3cd6e60de43821d8bb64
ToppCell3'-Airway_Nasal-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

ZUP1 ENAM DACT1 GZMB ZNF682

1.58e-041701335db0ec8b7ecbb4db108fc35c564df4b740f65cc8f
ToppCell3'-Airway_Nasal-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell-Plasmacytoid_DCs-Plasmacytoid_DCs_L.1.5.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

ZUP1 ENAM DACT1 GZMB ZNF682

1.58e-04170133588f6804e973863245ca1c7e5e6656d4a8b824da9
ToppCell3'-Airway_Nasal-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell-Plasmacytoid_DCs|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

ZUP1 ENAM DACT1 GZMB ZNF682

1.58e-041701335dad3aaf7d9f7bafdbddee51610f03f2359e587ae
ToppCellControl-Epithelial_cells-AT1|Control / group, cell type (main and fine annotations)

MAGI3 STOX2 ZFYVE9 RBMS3 LIMCH1

1.76e-041741335548d7f2b958a2bfd2c95eb049ceaab55a559c77d
ToppCellCOPD-Myeloid-pDC|World / Disease state, Lineage and Cell class

ENAM GZMB MED12L PDZRN3 NOTCH4

1.76e-041741335be8227398300711ccda5ecc41ad34064bb246b19
ToppCellCOVID-matDC-|COVID / Condition, Cell_class and T cell subcluster

ADAMTS8 PHGDH ASXL3 MED12L LIMCH1

1.81e-041751335db5e170411dfa62074c4b8311bb8c589d1c4279b
ToppCellCOVID-matDC|COVID / Condition, Cell_class and T cell subcluster

ADAMTS8 PHGDH ASXL3 MED12L LIMCH1

1.81e-041751335e2b638109c9ffd10430e6e134035622b7605ce23
ToppCellPND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-Treg-Treg_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

INTS7 TNFRSF4 BRCA1 GZMB MKI67

1.86e-0417613359e719e6323597ecfc758c957256872cd4ae24d4d
ToppCellControl-Lymphoid-pDC|Control / Condition, Lineage and Cell class

CETP DACT1 ZNF556 GZMB MED12L

1.86e-0417613355de16ff65476bde8b23322a44e11412e14f1bafe
ToppCellPBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

WAPL TUT7 SLF2 GZMH GZMB

1.91e-041771335d3e6c768b88b7906f3c7fdd00ba20842212c14b1
ToppCellPBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

WAPL TUT7 SLF2 GZMH GZMB

1.91e-041771335f8f101c772c043636bedd6b2ec81409b1d2599bf
ToppCellChildren_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor

ADAMTS8 IRAG1 SCUBE1 MEIOSIN PDZRN3

1.91e-041771335b59967219f7d874805768e247c0eb2bc4d4420c8
ToppCellCOVID-19_Mild-Lymphoid_T/NK-NK_activated|COVID-19_Mild / Disease group, lineage and cell class

WAPL TUT7 SLF2 GZMH GZMB

1.91e-0417713356978a22fef40c8b455342373abe7593f5ede0fa4
ToppCellPBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)

WAPL TUT7 SLF2 GZMH GZMB

1.91e-041771335936ab2b180a052387124f68d0c7f41c0b164e748
ToppCellPBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

WAPL TUT7 SLF2 GZMH GZMB

1.91e-041771335d5aeda113afaa2425874394610344570c9078478
ToppCellCOPD-Myeloid-pDC|COPD / Disease state, Lineage and Cell class

ENAM GZMB MED12L PDZRN3 NOTCH4

1.91e-041771335415aa023195a7f961c09529f65cdcc7bb90eaf5d
ToppCell5'-Adult-LymphNode-Endothelial-blood_vessel_EC-arterial_capillary|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

CETP TNFRSF4 FMNL3 MCTP1 NOTCH4

1.96e-041781335360d7a987f91d6d721487a921824057ec31a7332
ToppCellCOVID-19-Epithelial_cells-AT1|COVID-19 / group, cell type (main and fine annotations)

MAGI3 GRHL2 STOX2 RBMS3 LIMCH1

2.01e-041791335a0b33bd69ffdfd5d38d80207fb40058a490aa19e
ToppCellCOPD-Myeloid-pDC|Myeloid / Disease state, Lineage and Cell class

ENAM GZMB MED12L PDZRN3 NOTCH4

2.01e-04179133529b058c5e33fda9f0d738c074bdb67ff16b9b6d5
ToppCellChildren_(3_yrs)-Mesenchymal-myofibroblast_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor

IRAG1 SCUBE1 RBMS3 GLI3 PDZRN3

2.06e-04180133501f2e5d96016823482f89ba503d007d4bd88eeac
ToppCell5'-GW_trimst-1-SmallIntestine-Endothelial-blood_vessel_EC-Fetal_arterial_EC|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

CETP CXCL1 CXCL2 TNFRSF4 NOTCH4

2.11e-0418113357d7d1edeae4e0ebe40b324d1231cd26e27ba9d42
ToppCell5'-Adult-LymphNode-Mesenchymal-fibroblastic-Transitional_Stromal_3_(C3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

MSC OVCH1 CXCL1 CXCL2 ZNF114

2.11e-041811335ab66a89f316b935d9ba1277426d976b1e9e39757
ToppCelllymphoid-NK_cell-TNFRSF18+IL7R+_NK_cell|World / Lineage, cell class and subclass

IMPDH1 TNFRSF4 STOX2 GZMH GZMB

2.11e-0418113350d096d7d557fd2e71b35e41816e11d7e83cd9210
ToppCell10x5'v1-week_17-19-Hematopoietic-MK-MK|week_17-19 / cell types per 3 fetal stages;per 3',per 5'

IRAG1 RYR2 AFAP1 MED12L CTDSPL

2.22e-0418313359c66a40c355387f805dbdca4162dd05af5c1d8d4
ToppCellnucseq-Epithelial-Epithelial_Alveolar-AT1-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

MAGI3 STOX2 ZFYVE9 RBMS3 LIMCH1

2.28e-04184133557c792e6e2fedba25d3350ffe649fd74750b579d
ToppCellControl-Neu_4|World / 5 Neutrophil clusters in COVID-19 patients

CCDC14 WAPL GEMIN5 ANKRD36C CTDSPL

2.28e-041841335ce7f044956613118ee2e9fb6af2455c3166cb414
ToppCellControl-immature_Neutrophil-|Control / Disease condition and Cell class

WAPL GEMIN5 ANKRD36C MKI67 CTDSPL

2.28e-041841335c4e8ba82a6aa76c46f05a71d5f1c7926555318cf
ToppCellControl-immature_Neutrophil|Control / Disease condition and Cell class

WAPL GEMIN5 ANKRD36C MKI67 CTDSPL

2.28e-0418413352fdae5c6b3eb2232881d933a8c1061fda3623016
ToppCellnucseq-Epithelial-Epithelial_Alveolar-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

MAGI3 STOX2 ZFYVE9 RBMS3 LIMCH1

2.28e-041841335d7bd0f0c607bade67c99e9fb3578a570298bf926
ToppCellControl-Epithelial_alveolar-AT_2-Differentiating_AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

SECISBP2L RAP1GDS1 MAGI3 GRHL2 LIMCH1

2.34e-0418513350d2add28ac1f4fa6de7699be009bf8391badaf4c
ToppCell3'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC-venous_capillary|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

CETP TNFRSF4 ADAD2 MCTP1 NOTCH4

2.34e-041851335a987dbf6adf533c5f8a0a8a465a6c8e67e0ffcc8
ToppCellCOVID-19-Epithelial_cells-Airway_club|COVID-19 / group, cell type (main and fine annotations)

MAGI3 GRHL2 STOX2 RBMS3 LIMCH1

2.34e-041851335cfe6fd73d817e173fe803bc1683c291d9bcb8608
ToppCellMultiple_Sclerosis-Myeloid-pDC|Multiple_Sclerosis / Disease, Lineage and Cell Type

ENAM RBMS3 GZMB CD68 NOTCH4

2.40e-041861335330a4f669adea91ff9f2dff2de2210f5e3401e19
ToppCellcontrol-Myeloid-pDC|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs

FMNL3 ENAM GZMB NOTCH4 AMIGO2

2.40e-041861335fccee4cfcc887358cf916d974f29627095b5ad9c
ToppCellFetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

SECISBP2L MAGI3 GRHL2 STOX2 LIMCH1

2.46e-0418713354ae7465174e0295d2c3b614b321a3b2f514dd22a
ToppCellPCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM2_(12)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung

SLC26A2 ADAMTS8 IRAG1 PRAG1 DACT1

2.46e-041871335387cb27c8a20031cd87381a9e1172f1f62e1488b
ToppCellControl-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations)

ADAMTS8 RYR2 RBMS3 LIMCH1 PDZRN3

2.46e-04187133592d468dde81125d51daf7abd4703741abe1ab91c
ToppCellAdult-Mesenchymal-matrix_fibroblast_1_cell-D175|Adult / Lineage, Cell type, age group and donor

ADAMTS8 RYR2 ASXL3 ZNF667 PDZRN3

2.46e-041871335e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f
ToppCelllymphoid-NK_cell-TNFRSF18+IL7R+_NK_cell|lymphoid / Lineage, cell class and subclass

IMPDH1 TNFRSF4 STOX2 GZMH GZMB

2.46e-04187133599dfa50f6325b0d66d23ee8dcaa6437e7161628a
Diseaseviral pneumonia (biomarker_via_orthology)

CXCL1 CXCL2

5.07e-0531222DOID:10533 (biomarker_via_orthology)
DiseaseCoronavirus infectious disease (biomarker_via_orthology)

CXCL1 CXCL2

5.07e-0531222DOID:0080599 (biomarker_via_orthology)
Diseaselower face morphology measurement

DCHS2 TRPS1 PRAG1 ANAPC1 VPS13B

9.22e-051091225EFO_0010948
DiseaseC-type mannose receptor 2 measurement

TLK2 MRC2

1.01e-0441222EFO_0020204
Diseasegranzyme b measurement

GZMH GZMB

1.01e-0441222EFO_0020418
Diseasemigraine disorder

WAPL NSD1 ANKRD36C IRAG1 MRC2 HMGXB3 LIMCH1 NOTCH4

1.23e-043571228MONDO_0005277
DiseaseFEV/FEC ratio

DCHS2 TUT7 TRPS1 SKIDA1 NSD1 ITGAV AFAP1 RBMS3 ANAPC1 MRC2 ZNF516 EPC1 ERCC6L2 MN1 PDZRN3

1.70e-04122812215EFO_0004713
Diseasehippocampal volume

RAP1GDS1 PRAG1 RYR2 DACT1 STOX2 GLI3 GZMB

2.44e-042971227EFO_0005035
Diseaseaspiration pneumonia (biomarker_via_orthology)

CXCL1 CXCL2

2.52e-0461222DOID:0050152 (biomarker_via_orthology)
Diseaserenal overload-type gout

SPATA31C2 SPATA31C1

2.52e-0461222EFO_0021525
Diseaseesophageal cancer (biomarker_via_orthology)

CXCL1 CXCL2

2.52e-0461222DOID:5041 (biomarker_via_orthology)
DiseaseAbnormal corpus callosum morphology

MED12L MN1

2.52e-0461222C1842581
DiseaseMammary Carcinoma, Human

CXCL2 PHGDH SLC22A18 BRCA1 NISCH GZMB CXCL9 MKI67 NOTCH4

3.44e-045251229C4704874
DiseaseMammary Neoplasms, Human

CXCL2 PHGDH SLC22A18 BRCA1 NISCH GZMB CXCL9 MKI67 NOTCH4

3.44e-045251229C1257931
DiseaseShock, Hemorrhagic

CXCL1 CXCL2

3.51e-0471222C0036982
DiseaseMammary Neoplasms

CXCL2 PHGDH SLC22A18 BRCA1 NISCH GZMB CXCL9 MKI67 NOTCH4

3.54e-045271229C1458155
DiseaseBreast Carcinoma

CXCL2 PHGDH SLC22A18 BRCA1 NISCH GZMB CXCL9 MKI67 NOTCH4

4.11e-045381229C0678222
Diseaseeosinophil cationic protein measurement

SPATA31C2 SPATA31C1

4.67e-0481222EFO_0010913
Diseasevitamin D-dependent rickets (implicated_via_orthology)

CXCL1 CXCL2

4.67e-0481222DOID:0080883 (implicated_via_orthology)
Diseasesevere acute respiratory syndrome (biomarker_via_orthology)

CXCL1 CXCL2

4.67e-0481222DOID:2945 (biomarker_via_orthology)
DiseaseMalignant neoplasm of breast

KDM3A CXCL2 PHGDH SLC22A18 BRCA1 HOOK1 ZNF644 NISCH GZMB CXCL9 MKI67 VPS13B NOTCH4

5.15e-04107412213C0006142
DiseaseIntellectual Disability

TLK2 IQSEC3 NSD1 APC BRCA1 MED12L MN1 ALG13

5.57e-044471228C3714756
Diseaselongitudinal alcohol consumption measurement

SPATA31C2 SPATA31C1

5.99e-0491222EFO_0007645
Diseasealcohol consumption measurement

SECISBP2L WAPL TRPS1 MAGI3 ADH4 DACT1 STOX2 RBMS3 GLI3 ASB3 ZNF516 ANKRD36 CPNE4 PHLPP2

6.30e-04124212214EFO_0007878
Diseasehippocampal CA4 volume

NUP210L DACT1 GLI3

6.55e-04411223EFO_0009396
Diseasecerebral palsy (implicated_via_orthology)

AGAP5 AGAP9

7.47e-04101222DOID:1969 (implicated_via_orthology)
Diseasepneumonia (biomarker_via_orthology)

CXCL1 CXCL2

9.10e-04111222DOID:552 (biomarker_via_orthology)
DiseaseAlzheimer disease, dementia, family history of Alzheimer’s disease

TRPS1 FMNL3 ASB3

1.04e-03481223EFO_0009268, MONDO_0001627, MONDO_0004975
Diseasebronchopulmonary dysplasia (biomarker_via_orthology)

CXCL1 CXCL2

1.09e-03121222DOID:11650 (biomarker_via_orthology)
Diseaseprostatitis (biomarker_via_orthology)

CXCL1 CXCL2

1.09e-03121222DOID:14654 (biomarker_via_orthology)
DiseaseBenign tumor of pancreas

APC BRCA1

1.28e-03131222C0347284
Diseaseegg allergy measurement, parental genotype effect measurement

SPATA31C2 SPATA31C1

1.28e-03131222EFO_0005939, EFO_0007018
Diseasebronchiolitis obliterans (is_marker_for)

GZMB CXCL9

1.28e-03131222DOID:2799 (is_marker_for)
Diseasebacterial pneumonia (biomarker_via_orthology)

CXCL1 CXCL2

1.49e-03141222DOID:874 (biomarker_via_orthology)
Diseaseneuroimaging measurement

SECISBP2L DCHS2 TRPS1 SKIDA1 APC IRAG1 DACT1 AFAP1 BRCA1 GLI3 MKX PDZRN3

1.61e-03106912212EFO_0004346
Diseaseamygdala volume change measurement

SPATA31C2 SPATA31C1

1.96e-03161222EFO_0021490
Diseasemigraine disorder, type 2 diabetes mellitus

AFAP1 GLI3 KIAA2012

1.99e-03601223MONDO_0005148, MONDO_0005277
Diseaseobesity (implicated_via_orthology)

KDM3A DCHS2 ADAMTS8 MED12L NOTCH4

2.04e-032151225DOID:9970 (implicated_via_orthology)
Diseasecup-to-disc ratio measurement

ADAMTS8 PRAG1 FMNL3 AFAP1 RBMS3 GLI3 MN1

2.12e-034301227EFO_0006939
Diseasecystic fibrosis (is_marker_for)

CXCL1 CXCL2 CXCL9

2.18e-03621223DOID:1485 (is_marker_for)
DiseaseLipidemias

CETP APC

2.21e-03171222C1706412
DiseaseHyperlipidemia

CETP APC

2.21e-03171222C0020473
DiseaseCOVID-19 (is_marker_for)

CXCL2 GZMB CXCL9

2.29e-03631223DOID:0080600 (is_marker_for)
Diseasecorneal resistance factor

ADAMTS8 AFAP1 RBMS3 ANAPC1 GLI3 ZNF516 EIF4E3

2.76e-034511227EFO_0010067
Diseaseosteochondrodysplasia (is_implicated_in)

SLC26A2 TRPS1

2.77e-03191222DOID:2256 (is_implicated_in)
DiseasePancreatic carcinoma

APC BRCA1

2.77e-03191222C0235974
Diseasehippocampal tail volume

DACT1 STOX2

2.77e-03191222EFO_0009398
DiseaseAnimal Mammary Neoplasms

TRPS1 APC BRCA1 MRC2

2.91e-031421224C0024667
DiseaseMammary Carcinoma, Animal

TRPS1 APC BRCA1 MRC2

2.91e-031421224C1257925
Diseasecorneal hysteresis

ADAMTS8 ANAPC1

3.07e-03201222EFO_0010066
Diseaseanorexia nervosa

MCTP1 ASB3 TSHZ1

3.09e-03701223MONDO_0005351
Diseaseemphysema imaging measurement

RBMS3 GZMB ASB3 LIMCH1

3.22e-031461224EFO_0007626
DiseaseBREAST CANCER

SLC22A18 BRCA1

3.38e-03211222114480
Diseaselevel of Phosphatidylcholine (16:1_18:2) in blood serum

CETP ESCO1

3.38e-03211222OBA_2045083
Diseasewellbeing measurement, alcohol consumption measurement

DACT1 RBMS3 CPNE4

3.61e-03741223EFO_0007869, EFO_0007878
Diseasedilated cardiomyopathy (biomarker_via_orthology)

CXCL1 CXCL2

3.71e-03221222DOID:12930 (biomarker_via_orthology)
Diseaselung carcinoma

SECISBP2L MAGI3 RBMS3 SLF2 DNAAF10 ASB3 NOTCH4

3.98e-034821227EFO_0001071
DiseaseDisproportionate short stature

SLC26A2 TRPS1 GLI3

4.04e-03771223C0878659

Protein segments in the cluster

PeptideGeneStartEntry
LAAAANCQVSKVPSS

EPC1

791

Q9H2F5
CPAGTANSKTEAKQQ

ADAD2

156

Q8NCV1
PKISCQNKGVVVNSS

CETP

346

P11597
AKSIASAPGKCQDSA

ALG13

136

Q9NP73
ACAPISSSKSNGLSK

AGAP9

396

Q5VTM2
NLCGKISNLKSPASD

ADH4

111

P08319
DPSGQASATCNKALK

ADAMTS8

861

Q9UP79
KPNLLKQETSSLACG

ARFGEF1

1716

Q9Y6D6
NSAAVLKKSQAAPGS

AFAP1

696

Q8N556
ATLKNGRKACLNPAS

CXCL1

76

P09341
SNKAQVKPGQTCSVA

GZMB

131

P10144
SSKAQVKPGQLCSVA

GZMH

131

P20718
IVSCTNKNLSKVPGN

AMIGO2

51

Q86SJ2
LQCGTVSSQKQPALK

ANKRD36

676

A6QL64
NVNCAVSSTGNTPLK

ANKRD61

226

A6NGH8
VDSARCKPGNNLTKS

CCDC14

656

Q49A88
TTSVLKNNLCPSGSN

CD81

166

P60033
SGPHKKNCVLNASSA

ATXN7L1

671

Q9ULK2
ALLQASSKTPVGCNA

ASXL3

1946

Q9C0F0
ASTAKKCVSCQNLNP

RANBP2

1366

P49792
ASATKCIACQNPGKQ

RANBP2

1621

P49792
SSNPLAGQRKLTCSQ

PDZRN3

596

Q9UPQ7
KTQINSLKNSVACPG

RBM48

246

Q5RL73
SLKNSVACPGAQKAI

RBM48

251

Q5RL73
AAGSKILASNSIICP

NSD1

1676

Q96L73
KGCVSDPLQTSGKAA

NSD1

2506

Q96L73
TLAKALNPGESTACQ

NR2C1

326

P13056
INSKSALCNADSPKD

PDS5A

1086

Q29RF7
SPAAAQKAVASLKAN

RBMS3

111

Q6XE24
DSPGAQATLKIALNC

INTS7

401

Q9NVH2
SNGCTAAQQRTKSTP

KIAA1107

326

Q9UPP5
GQPASISCKSSQSLL

IGKV2D-29

36

A0A075B6S2
QACEGNLPKGKSVLS

ANAPC1

986

Q9H1A4
QCGTVSSQKQPALKA

ANKRD36C

711

Q5JPF3
LNPNKTKVQGSCEGA

CD68

196

P34810
DCVNQCKSKPGLSTS

MBD3L1

11

Q8WWY6
KKGIAFPTSISVNNC

PA2G4

71

Q9UQ80
FQSQLLCQGPSLASK

KIAA0100

236

Q14667
ACGAGIQASKLKSTP

GLI3

1271

P10071
QKSSSLPGTACLEQL

MCTP1

196

Q6DN14
ASQNPKSCGKSISIE

MED12L

1221

Q86YW9
LSPSKGENKSCQVST

MAGI3

1256

Q5TCQ9
KPIKCGTFGATSLQQ

DNAAF10

66

Q96MX6
LCSSPLFKGGQNSLA

HMGXB3

751

Q12766
KLANQNSSRSCGPSE

IRAG1

651

Q9Y6F6
NLAQGKDKLQGTTSC

MKX

316

Q8IYA7
EKLKLGCSPANGNST

NUDT4

141

Q9NZJ9
CSSPKGSARNSLVKA

COIL

216

P38432
TNFPLKCQKQRGAST

FAM157C

336

P0CG43
AQKTGEPQSCINKAL

KIAA2012

681

Q0VF49
PSICKKAGQLSQGAA

MRC2

501

Q9UBG0
FSAQNAAKQPSDKCS

MKI67

811

P46013
QQGTKTLSFKPCGAQ

IQSEC3

996

Q9UPP2
SPSSQKSCLQGACQK

MEIOSIN

161

C9JSJ3
SPLASGAVANKLCQS

UQCRC1

326

P31930
LPGATAAECASNLKK

EIF4E3

61

Q8N5X7
ASKDSQKQLLCGAAV

IMPDH1

236

P20839
VQLSAPCNLGSLQSK

DCHS2

581

Q6V1P9
KLTNAPGSFTKCSNT

BRCA1

701

P38398
SGANVNCQALDKATP

ASB3

201

Q9Y575
SSLVKNNCPDKTSAA

HECTD1

1361

Q9ULT8
CNSSSDGKLAAIPLQ

GRHL2

446

Q6ISB3
KAGVNSDSPNNCSGK

KDM3A

456

Q9Y4C1
ATLKNGQKACLNPAS

CXCL2

76

P19875
NLKNSKQACLPSGGI

DACT1

391

Q9NYF0
PGAGEKASQCNVSLK

CTDSPL

21

O15194
GPALDLICSKNKTAQ

FMNL3

616

Q8IVF7
AANTLGIFNSPCLTK

CPNE4

11

Q96A23
KPSTTLDGTNKLCQF

DUSP16

431

Q9BY84
QDNKTCSLPGTALKV

ITGAV

486

P06756
SLLTPQSSCKAKVAN

RAP1GDS1

56

P52306
SGPSKLCQALAINKS

MPG

216

P29372
GQPASISCKSSQSLL

IGKV2-29

36

A2NJV5
FVAQSCQPASLKGNS

KRTAP27-1

126

Q3LI81
TLKNGVQTCLNPDSA

CXCL9

66

Q07325
TKPVKCILNGINSSA

ESCO1

371

Q5FWF5
SSLQSKNTPCLKNDL

ENAM

976

Q9NRM1
NTASPCQDVKQLTSG

HOOK1

26

Q9UJC3
TTDACQKGLPKAQTG

DIP2A

456

Q14689
KASSSPGQLTLLQCG

ERCC6L2

791

Q5T890
AKTSPRAQLSCSKAG

SCUBE1

411

Q8IWY4
PCLKVTQKSFGSQNS

RYR2

1281

Q92736
QSPNRSISGKKLCSS

LIMCH1

1001

Q9UPQ0
NLKGFCTPNQALAIT

NUP210L

1591

Q5VU65
NKPSSKDNLFGQSCL

MN1

811

Q10571
AQTAVPVLCGSALKN

GFM2

321

Q969S9
GVACPASQNKVQALS

SPATA31C2

376

B4DYI2
NLVANDGKNSCPVSS

SPATA22

136

Q8NHS9
TSNLAAPKSGKACVN

SPATA31A6

766

Q5VVP1
APKSGKACVNTAQVL

SPATA31A6

771

Q5VVP1
AASSQQATLKSQGCP

SPATA31A6

1261

Q5VVP1
PSKLAVQVESCGKSN

RESF1

1481

Q9HCM1
INGPASLQTNNKCKT

OVCH1

811

Q7RTY7
TGVACPASQNKVQAL

SPATA31A7

521

Q8IWB4
SNLAAPKSGKACVNT

SPATA31A7

771

Q8IWB4
PKSGKACVNTAQVLS

SPATA31A7

776

Q8IWB4
LAQSQGLSCTLGSPK

SKIDA1

751

Q1XH10
GEKKCLAPIANTTNG

SETX

1106

Q7Z333
PGQQKSSNCSSLNKE

SECISBP2L

1076

Q93073
GQRCNVLKKSASSFP

SPATA31D4

736

Q6ZUB0
SAGSSLVPLNAKNCA

SLF2

481

Q8IX21
TGVACPASQNKVQAL

SPATA31C1

381

P0DKV0
LPLSSCQKAALSQGI

NOTCH4

881

Q99466
CIPASTKGAKTDAQA

SLC22A18

201

Q96BI1
SKGPLNSESSNQSLC

TLK2

26

Q86UE8
ACAPISSSKSNGLSK

AGAP5

351

A6NIR3
AQSRSGQPQKAATCK

APC

1236

P25054
GQPQKAATCKVSSIN

APC

1241

P25054
FNAAQNKAPGSKGSC

CLEC4F

546

Q8N1N0
VCAQLSAGSTDPGKK

CNOT10

326

Q9H9A5
LVSAQQKAPTRKSGC

ZNF667

111

Q5HYK9
TGVACPASQNKVQAL

SPATA31A3

521

Q5VYP0
SNLAAPKSGKACVNT

SPATA31A3

771

Q5VYP0
PKSGKACVNTAQVLS

SPATA31A3

776

Q5VYP0
AQSEGPSSLCGKLKQ

ZBTB48

181

P10074
QANCQGLSPVSVASK

TRPS1

171

Q9UHF7
SPTKSASACNRLLNG

ZNF516

116

Q92618
GQRCNVLKKSASSFP

SPATA31D3

736

P0C874
DAPGNVLCALSQKSS

ZBTB21

371

Q9ULJ3
SGNKLKTIPTTIANC

PHLPP2

676

Q6ZVD8
SLIKNTGVACPASQN

SPATA31A1

516

Q5TZJ5
TGVACPASQNKVQAL

SPATA31A1

521

Q5TZJ5
SNLAAPKSGKACVNT

SPATA31A1

771

Q5TZJ5
PKSGKACVNTAQVLS

SPATA31A1

776

Q5TZJ5
QTKQCSGDSAKLPAG

SPEM3

496

A0A1B0GUW6
TGVACPASQNKVQAL

SPATA31A5

521

Q5VU36
SNLAAPKSGKACVNT

SPATA31A5

771

Q5VU36
PKSGKACVNTAQVLS

SPATA31A5

776

Q5VU36
VSKNQKGVCVPNGLS

SLC26A2

721

P50443
KLQKPSNCLQASVTS

STOX2

911

Q9P2F5
QNGSQKPRSTTQCKS

TTBK2

1116

Q6IQ55
CSSKNVRTQIGQKPS

ZNF556

411

Q9HAH1
SQLCKSTANGPDKNE

GEMIN5

1391

Q8TEQ6
LQQGKPTCASGDAKT

NISCH

161

Q9Y2I1
NGLNQCLSTLPSKIF

ZNF682

131

O95780
SLPVSSKNLAQVKCS

WAPL

81

Q7Z5K2
QCKGAPSASSSQLSV

PRAG1

911

Q86YV5
NCTLAGKHTLQPASN

TNFRSF4

146

P43489
NKKLPTSASVGCDIQ

ZNF644

191

Q9H582
ILSGCASNHPKNSAQ

ZUP1

91

Q96AP4
TSKPCLLASLSNLNG

VPS13B

2151

Q7Z7G8
TSLKNAGNCLSPAVI

PHGDH

361

O43175
SKSQNKCKPSQGLST

TAPT1

481

Q6NXT6
KCKPSQGLSTEENLS

TAPT1

486

Q6NXT6
GATSSAANTCKVQPL

TUT7

681

Q5VYS8
TEPLKAKVTNGCNNL

TSHZ1

716

Q6ZSZ6
AKLGENSATNVCSPS

ZFYVE9

621

O95405
KSNSKTECVSPIQCG

ZNF814

196

B7Z6K7
KKDCQTGATSANAPN

ZNF114

276

Q8NC26
QLIESCGKPSSLASN

ZNF518B

671

Q9C0D4
SLKTNSASKSAPGCQ

INSYN2B

341

A6NMK8
PAKGSAAECKQSQRN

MSC

96

O60682